Super Systems debuts new photochromic lenses

Article

Super Systems introduces Conversion Clear N Dark 1.56 photochromic lenses, which incorporate automatic tint adjustment relative to ultraviolet ray exposure from the sun.

Cincinnati, OH-Super Systems introduces Conversion Clear N Dark 1.56 photochromic lenses, which incorporate automatic tint adjustment relative to ultraviolet ray exposure from the sun. Within seconds of stepping outside, the Conversion lenses will shift to a true gray color while maintaining 100% UVA protection and consistent vision clarity.

The Conversion Clear N Dark lens provides a quick and effective transition with value pricing.

Conversion Clear N Darks are finished single-vision lenses with a power range of -6.00 D to +4.00 D 2.00 D cylinder. The lenses also include AR coating.

The Conversion Clear N Dark lenses are currently available in gray. A brown color is in development and will be released in the near future.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Rachelle Lin, OD, MS, FAAO
Paul Karpecki, OD, FAAO
Melissa Barnett, OD, FAAO, FSLS, FBCLA, gave 2 presentations alongside other ODs and MDs at CRU 2025.
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
© 2025 MJH Life Sciences

All rights reserved.